H3N2 Wisconsin/67/05

H3N2 Influenza-A Virus Wisconsin/67/05
Cat. No.
BT26599
Source
Synonyms
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 90.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Wisconsin/67/05. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient.

Product Specs

Introduction
H3N2 is a subtype of the influenza A virus, named after the hemagglutinin (H) and neuraminidase (N) proteins on its surface. This subtype is known to exchange internal protein genes with other influenza subtypes and has often been more prevalent than H1N1, H1N2, and influenza B. H3N2 originated from the H2N2 subtype through antigenic shift, a process where genes from different subtypes recombine. Both H2N2 and H3N2 contained genes from avian influenza viruses.
Description
This product consists of allantoic fluid from 10-day-old embryonated eggs that were inoculated with the influenza A virus strain A/Wisconsin/67/05. The virus was then purified using ultracentrifugation with a 10-40% sucrose gradient.
Inactivation
This product has been inactivated using thimerosal and beta-propiolactone treatment. While this treatment is in line with established inactivation methods, standard microbiological/viral safe handling practices and techniques are essential when working with this product.
Physical Appearance
The product is a sterile-filtered solution that is colorless.
Formulation
The H3N2 A/Wisconsin/67/05 solution is formulated with STE, 0.1% sodium azide (NaN3), and 0.005% thimerosal.
Stability
For optimal stability, A/Wisconsin/67/05 should be stored at temperatures below -18°C. While it can remain stable at 4°C for up to 4 weeks, it's important to avoid repeated freeze-thaw cycles.
Purity
The purity of this product exceeds 90.0%, as determined by SDS-PAGE analysis.
Immunological Activity
Serological studies of influenza A virus, immunogen for antibody production.
Tested with anti-influenza A monoclonal antibodies in ELISA.

Product Science Overview

Introduction

The H3N2 Influenza-A Virus Wisconsin/67/05 is a subtype of the Influenza A virus, which is known for causing seasonal flu outbreaks in humans. This particular strain, identified in Wisconsin in 2005, has been a significant focus of research due to its impact on public health and its role in the evolution of influenza viruses.

Evolution and Genetic Characteristics

The H3N2 subtype evolved from the H2N2 subtype through a process known as antigenic shift, where genes from multiple subtypes reassorted to form a new virus . This process allows the virus to evade the immune system, leading to new outbreaks. The H3N2 strain has been dominant in various flu seasons, often outcompeting other subtypes like H1N1 and H1N2 .

The H3N2 Influenza-A Virus Wisconsin/67/05 strain was included in the 2006-2007 influenza vaccine for the northern hemisphere due to its prevalence and impact . The strain’s genetic makeup includes specific changes at antigenic sites, which are regions of the virus recognized by the immune system .

Epidemiology and Impact

H3N2 has been responsible for several significant flu outbreaks, including the Hong Kong Flu pandemic of 1968-1969, which resulted in up to 750,000 deaths . The Wisconsin/67/05 strain contributed to the seasonal flu outbreaks in the mid-2000s, highlighting the importance of continuous monitoring and vaccine updates.

Research and Vaccine Development

Research on the H3N2 Influenza-A Virus Wisconsin/67/05 has been crucial for understanding the evolution and spread of influenza viruses. Studies have shown that the virus undergoes frequent genetic changes, particularly in the hemagglutinin (HA) protein, which is a key target for the immune response . These changes necessitate regular updates to the flu vaccine to ensure its effectiveness.

The strain has been propagated in specific pathogen-free (SPF) chicken embryonated eggs for research purposes, aiding in the development of vaccines and antiviral treatments . The continuous study of this strain and others like it helps predict future flu seasons and improve public health responses.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.